Giuseppe Giannini

Pharmacophore-Based Virtual Screening for Identification of Negative Modulators of GLI1 as Potential Anticancer Agents.

Fabrizio Manetti, Barbara Stecca, Roberta Santini, 2020, ACS medicinal chemistry letters.

Azetidinones as Zinc‐Binding Groups to Design Selective HDAC8 Inhibitors

Walter Cabri, Sergio Penco, Grazia Gallo, 2009, ChemMedChem.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

An integrated approach identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated genes in developing cerebellum and medulloblastoma.

Giuseppe Giannini, L. Di Marcotullio, I. Screpanti, 2008, Neoplasia.

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Wei Lu, Wei Zheng, Mads Thomassen, 2013, Nature Genetics.

Human MRE11 is inactivated in mismatch repair‐deficient cancers

Alessandra Viel, Fabio Cerignoli, Marco Crescenzi, 2002, EMBO reports.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Mads Thomassen, Nina Ditsch, Muhammad Usman Rashid, 2015, JAMA.

Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors.

Benito Casu, Marco Presta, Sergio Penco, 2002, Biochemistry.

MiR‐128 up‐regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness

Giuseppe Giannini, C. Dominici, H. McDowell, 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Stefania Tommasi, Laura Cortesi, Mads Thomassen, 2019, Cancer research.